IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Paradigm Biocapital Advisors LP

Q2 2026 Holdings

Filed 2026-08-14 | 28 holdings | $5.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$1.2B6,361,32322.3%
Nuvalent Inc(NUVL)COM670703107$731.7M5,924,43313.7%
Edgewise Therapeutics Inc(EWTX)COM28036F105$415.1M10,215,4557.8%
Genmab A/S(GMAB)SPONSORED ADS372303206$360.8M13,133,1316.8%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$341.0M3,840,7786.4%
Apogee Therapeutics Inc(APGE)COM03770N101$209.2M1,576,3853.9%
Oruka Therapeutics Inc(ORKA)COM687604108$204.1M2,144,5263.8%
Tango Therapeutics Inc(TNGX)COM87583X109$198.7M6,357,5233.7%
Belite BIO Inc(BLTE)SPONSORED ADS07782B104$189.8M1,232,8773.6%
Erasca Inc(ERAS)COM29479A108$175.0M9,550,0003.3%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$174.7M2,775,6493.3%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$144.5M480,0002.7%
Insmed Inc(INSM)COM PAR $.01457669307$141.4M1,325,9772.6%
MBX Biosciences Inc(MBX)COM55287L101$138.4M2,508,0152.6%
Vaxcyte Inc(PCVX)COM92243G108$123.7M2,127,8522.3%
Viridian Therapeutics Inc(VRDN)COM92790C104$123.5M6,723,7882.3%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$108.5M8,670,5762.0%
Jade Biosciences Inc(JBIO)COM NEW008064206$63.5M2,857,4051.2%
Tyra Biosciences Inc(TYRA)COM90240B106$58.4M1,828,6071.1%
Assembly Biosciences Inc(ASMB)COM NEW045396207$42.7M1,553,7480.8%
Eyepoint Inc(EYPT)COM NEW30233G209$41.3M2,890,3970.8%
Achieve Life Science Inc(ACHV)COM004468500$32.3M4,951,8560.6%
VOR Biopharma Inc(VOR)COM NEW929033207$32.2M1,750,0000.6%
Maplight Therapeutics Inc(MPLT)COM56565P103$24.6M685,8520.5%
Kardigan Inc(KARD)COM485925101$21.5M900,0000.4%
Lexeo Therapeutics Inc(LXEO)COM52886X107$19.4M4,175,3820.4%
Editas Medicine Inc(EDIT)COM28106W103$18.1M5,586,6250.3%
Inventiva SA(IVA)ADS46124U107$15.1M4,000,0000.3%